Cargando…

A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility

OBJECTIVE: Many cases of obstructive sleep apnea (OSA) involve collapse of the tongue base and soft palate during sleep, causing occlusion of the upper airway and leading to oxygen desaturation. Existing therapies can be effective, but they are plagued by patient adherence issues and the invasivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavelec, Vaclav, Rotenberg, Brian W, Maurer, Joachim T, Gillis, Edward, Verse, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862357/
https://www.ncbi.nlm.nih.gov/pubmed/27217804
http://dx.doi.org/10.2147/NSS.S103702
_version_ 1782431358345281536
author Pavelec, Vaclav
Rotenberg, Brian W
Maurer, Joachim T
Gillis, Edward
Verse, Thomas
author_facet Pavelec, Vaclav
Rotenberg, Brian W
Maurer, Joachim T
Gillis, Edward
Verse, Thomas
author_sort Pavelec, Vaclav
collection PubMed
description OBJECTIVE: Many cases of obstructive sleep apnea (OSA) involve collapse of the tongue base and soft palate during sleep, causing occlusion of the upper airway and leading to oxygen desaturation. Existing therapies can be effective, but they are plagued by patient adherence issues and the invasiveness of surgical approaches. A new, minimally invasive implant for OSA has been developed, which is elastic and contracts a few weeks after deployment, stabilizing the surrounding soft tissue. The device has had good outcomes in preclinical testing; this report describes the preliminary feasibility and safety of its implementation in humans. PATIENTS AND METHODS: A prospective, multicenter, single-arm feasibility study was conducted. Subjects were adults with moderate-to-severe OSA who had previously failed or refused conventional continuous positive airway pressure treatment. Intraoperative feasibility data, postoperative pain, and safety information were collected for a 30-day postoperative period. RESULTS: Forty subjects participated (37 men, three women; average age of 46.1 years); each received two tongue-base implants and two soft-palate implants. Surgical procedure time averaged 43 minutes. Postsurgical pain resolved readily in most cases; at 30 days post implantation, <20% of subjects reported pain, which averaged less than two out of ten. Adverse events were generally the mild and expected sequelae of a surgical procedure with general anesthesia and intraoral manipulation. The device was well tolerated. Implant extrusions were reported with soft-palate implants (n=12), while tongue-base implants required few revisions (n=2). Quantitative and qualitative sleep effectiveness outcomes (including full-night polysomnographic and quality-of-life measures) will be presented in a subsequent report. CONCLUSION: Implantation of the device was feasible. Although a relatively high rate of extrusions occurred in the now-discontinued palate implants, tongue-base implants were largely stable and well tolerated. The minimally invasive and maintenance-free implant may provide a new alternative to higher morbidity surgical procedures.
format Online
Article
Text
id pubmed-4862357
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48623572016-05-23 A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility Pavelec, Vaclav Rotenberg, Brian W Maurer, Joachim T Gillis, Edward Verse, Thomas Nat Sci Sleep Original Research OBJECTIVE: Many cases of obstructive sleep apnea (OSA) involve collapse of the tongue base and soft palate during sleep, causing occlusion of the upper airway and leading to oxygen desaturation. Existing therapies can be effective, but they are plagued by patient adherence issues and the invasiveness of surgical approaches. A new, minimally invasive implant for OSA has been developed, which is elastic and contracts a few weeks after deployment, stabilizing the surrounding soft tissue. The device has had good outcomes in preclinical testing; this report describes the preliminary feasibility and safety of its implementation in humans. PATIENTS AND METHODS: A prospective, multicenter, single-arm feasibility study was conducted. Subjects were adults with moderate-to-severe OSA who had previously failed or refused conventional continuous positive airway pressure treatment. Intraoperative feasibility data, postoperative pain, and safety information were collected for a 30-day postoperative period. RESULTS: Forty subjects participated (37 men, three women; average age of 46.1 years); each received two tongue-base implants and two soft-palate implants. Surgical procedure time averaged 43 minutes. Postsurgical pain resolved readily in most cases; at 30 days post implantation, <20% of subjects reported pain, which averaged less than two out of ten. Adverse events were generally the mild and expected sequelae of a surgical procedure with general anesthesia and intraoral manipulation. The device was well tolerated. Implant extrusions were reported with soft-palate implants (n=12), while tongue-base implants required few revisions (n=2). Quantitative and qualitative sleep effectiveness outcomes (including full-night polysomnographic and quality-of-life measures) will be presented in a subsequent report. CONCLUSION: Implantation of the device was feasible. Although a relatively high rate of extrusions occurred in the now-discontinued palate implants, tongue-base implants were largely stable and well tolerated. The minimally invasive and maintenance-free implant may provide a new alternative to higher morbidity surgical procedures. Dove Medical Press 2016-05-04 /pmc/articles/PMC4862357/ /pubmed/27217804 http://dx.doi.org/10.2147/NSS.S103702 Text en © 2016 Pavelec et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Pavelec, Vaclav
Rotenberg, Brian W
Maurer, Joachim T
Gillis, Edward
Verse, Thomas
A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
title A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
title_full A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
title_fullStr A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
title_full_unstemmed A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
title_short A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
title_sort novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862357/
https://www.ncbi.nlm.nih.gov/pubmed/27217804
http://dx.doi.org/10.2147/NSS.S103702
work_keys_str_mv AT pavelecvaclav anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT rotenbergbrianw anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT maurerjoachimt anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT gillisedward anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT versethomas anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT pavelecvaclav novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT rotenbergbrianw novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT maurerjoachimt novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT gillisedward novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility
AT versethomas novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility